Petr F. Kuzma is VP & Research and Development at Valera Pharmaceuticals Inc (VLRX). They have made 1 open-market trade across 1 company since 2006, most recently 2007-04-17.
CIK 0001322963
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $10K since 2006, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VLRX | 1,100 | $282 |
Shares reported on the most recent Form 4, priced at the 2006-02-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VLRX | BUY | 2006-02-02 | 2006-02-02 | $9.00 | $10K | -23.3% | -25.1% | -25.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.